Bausch Health Companies Inc. (BHC) is the 119th largest of 300 Generic Drugs companies by market capitalisation, at 2.39 Bn, behind Supernus Pharmaceuticals, Inc. at 2.43 Bn. The table below compares all 300 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TEVA | Teva Pharmaceutical Industries Ltd | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 42.87 Bn | 61.60 | 2.48 | 39.22 Bn |
| 2 | VTRS | Viatris Inc | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 19.25 Bn | -46.86 | 1.31 | 18.36 Bn |
| 3 | RDY | Dr Reddys Laboratories Ltd | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 9.88 Bn | 783.09 | 2.70 | 9.71 Bn |
| 4 | AMRX | Amneal Pharmaceuticals, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 5.50 Bn | 25.54 | 1.76 | 5.37 Bn |
| 5 | BHC | Bausch Health Companies Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 2.39 Bn | -2.18 | 0.22 | 0.55 Bn |
| 6 | ALVO | Alvotech | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.50 Bn | -5.38 | 4.37 | 1.36 Bn |
| 7 | ANIP | Ani Pharmaceuticals Inc | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.50 Bn | 13.87 | 1.53 | 1.14 Bn |
| 8 | AMPH | Amphastar Pharmaceuticals, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.00 Bn | 11.93 | 1.36 | 0.71 Bn |
| 9 | FENC | Fennec Pharmaceuticals Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.41 Bn | -93.06 | 7.68 | 0.37 Bn |
| 10 | RDHL | RedHill Biopharma Ltd. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.18 Bn | -434.89 | 37.17 | 0.18 Bn |
| 11 | NTRB | NutriBand Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -9.87 | 42.49 | 0.07 Bn |
| 12 | BGM | BGM Group Ltd. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | — | — | 0.02 Bn |
| 13 | ETST | Earth Science Tech, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | 6.76 | 0.72 | 0.02 Bn |
| 14 | NXPL | NextPlat Corp | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -2.47 | 0.50 | 0.01 Bn |
| 15 | COSM | Cosmos Health Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.78 | 0.22 | 0.01 Bn |
| 16 | SCNX | Scienture Holdings, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.90 | 34.97 | 0.01 Bn |
| 17 | AEON | AEON Biopharma, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.25 | — | 0.01 Bn |
| 18 | PMHS | Polomar Health Services, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.59 | 1.78 | 0.01 Bn |
| 19 | SXTP | 60 Degrees Pharmaceuticals, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.38 | 2.22 | 0.00 Bn |
| 20 | SBFM | Sunshine Biopharma Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.26 | 0.04 | -0.01 Bn |
| 21 | QNRX | Quoin Pharmaceuticals, Ltd. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | 0.00 Bn |
| 22 | PRFX | PRF Technologies Ltd. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.18 | 53.74 | -0.01 Bn |
| 23 | GRMLW | Greenland Mines Ltd | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.02 | — | -0.01 Bn |
| 24 | JNJ | Johnson & Johnson | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 646.03 Bn | 30.71 | 6.60 | 625.27 Bn |
| 25 | ABBV | AbbVie Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 441.56 Bn | 69.91 | 6.86 | 434.99 Bn |
| 26 | MRK | Merck & Co., Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 364.45 Bn | 115.00 | 5.47 | 357.31 Bn |
| 27 | NVS | Novartis Ag | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 267.46 Bn | 9.29 | 3.89 | 259.77 Bn |
| 28 | TMO | Thermo Fisher Scientific Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 224.65 Bn | 31.91 | 4.85 | 220.58 Bn |
| 29 | ABT | Abbott Laboratories | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 184.89 Bn | 34.08 | 3.97 | 179.29 Bn |
| 30 | GILD | Gilead Sciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 181.43 Bn | -62.67 | 5.96 | 178.25 Bn |
| 31 | PFE | Pfizer Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 158.77 Bn | 36.35 | 2.49 | 147.08 Bn |
| 32 | VRTX | Vertex Pharmaceuticals Inc / Ma | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 132.46 Bn | 30.07 | 10.52 | 124.61 Bn |
| 33 | ISRG | Intuitive Surgical Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 124.33 Bn | 39.37 | 11.27 | 119.12 Bn |
| 34 | MDT | Medtronic plc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 118.33 Bn | 22.45 | 3.15 | 109.51 Bn |
| 35 | BSX | Boston Scientific Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 66.98 Bn | 18.23 | 3.19 | 66.44 Bn |
| 36 | TEL | TE Connectivity plc | secondary | I-07 | Machinery | IG-02 | 59.53 Bn | 19.28 | 3.08 | 58.29 Bn |
| 37 | AME | Ametek Inc/ | secondary | I-04 | Machinery | IG-02 | 54.17 Bn | 34.37 | 6.89 | 53.68 Bn |
| 38 | SNY | Sanofi | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 52.48 Bn | 11.26 | 0.98 | 45.10 Bn |
| 39 | EW | Edwards Lifesciences Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 49.79 Bn | 49.61 | 7.65 | 45.54 Bn |
| 40 | BDX | Becton Dickinson & Co | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 49.43 Bn | 52.47 | 2.13 | 48.56 Bn |
| 41 | RVMD | Revolution Medicines, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 44.15 Bn | -24.97 | — | 44.15 Bn |
| 42 | ALC | Alcon Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 33.96 Bn | 52.81 | 3.16 | 32.50 Bn |
| 43 | DXCM | Dexcom Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 32.28 Bn | 32.29 | 6.50 | 30.33 Bn |
| 44 | BIIB | Biogen Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 31.48 Bn | 37.72 | 3.14 | 30.19 Bn |
| 45 | ZTS | Zoetis Inc. | secondary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 30.66 Bn | 9.37 | 3.22 | 28.99 Bn |
| 46 | GEHC | GE HealthCare Technologies Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 30.07 Bn | 14.66 | 1.41 | 27.96 Bn |
| 47 | ROIV | Roivant Sciences Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 29.81 Bn | -20.09 | 2,729.23 | 29.81 Bn |
| 48 | INSM | INSMED Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 28.11 Bn | -32.11 | 24.71 | 26.95 Bn |
| 49 | INCY | Incyte Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 25.31 Bn | 15.70 | 4.35 | 20.77 Bn |
| 50 | WST | West Pharmaceutical Services Inc | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 23.95 Bn | 43.59 | 7.20 | 23.51 Bn |
| 51 | IFF | International Flavors & Fragrances Inc | secondary | M-02 | Chemicals | MG-01 | 21.48 Bn | 73.57 | 2.15 | 20.91 Bn |
| 52 | UTHR | UNITED THERAPEUTICS Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 21.29 Bn | 16.24 | 6.75 | 18.63 Bn |
| 53 | STE | STERIS plc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 21.14 Bn | 26.16 | 3.50 | 20.66 Bn |
| 54 | ZBH | Zimmer Biomet Holdings, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 18.20 Bn | 21.48 | 2.14 | 17.79 Bn |
| 55 | NDSN | Nordson Corp | secondary | I-04 | Machinery | IG-02 | 17.51 Bn | 31.53 | 5.88 | 17.39 Bn |
| 56 | FTV | Fortive Corp | secondary | I-04 | Machinery | IG-02 | 17.12 Bn | 32.04 | 3.97 | 16.75 Bn |
| 57 | IEX | Idex Corp /De/ | secondary | I-10 | Machinery | IG-02 | 16.74 Bn | 32.23 | 4.67 | 16.12 Bn |
| 58 | NBIX | Neurocrine Biosciences Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.48 Bn | 21.94 | 4.59 | 15.09 Bn |
| 59 | SOLV | Solventum Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 15.46 Bn | 10.77 | 1.86 | 15.06 Bn |
| 60 | JAZZ | Jazz Pharmaceuticals plc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.14 Bn | 16.09 | 3.29 | 13.52 Bn |
| 61 | BWXT | BWX Technologies, Inc. | secondary | I-39 | Clean Energy Equipment | IG-10 | 14.50 Bn | 40.71 | 4.13 | 13.89 Bn |
| 62 | EXEL | Exelixis, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 14.42 Bn | 16.76 | 5.92 | 13.58 Bn |
| 63 | CRL | Charles River Laboratories International, Inc. | secondary | H-11 | Pharma Services | HG-03 | 13.29 Bn | -55.93 | 3.32 | 13.10 Bn |
| 64 | COO | Cooper Companies, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 13.11 Bn | 55.61 | 3.10 | 12.97 Bn |
| 65 | BAX | Baxter International Inc | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 12.85 Bn | 558.81 | 1.16 | 10.70 Bn |
| 66 | HALO | Halozyme Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 12.63 Bn | 30.53 | 7.59 | 12.39 Bn |
| 67 | PEN | Penumbra Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 12.59 Bn | 78.43 | 8.37 | 11.93 Bn |
| 68 | CORT | Corcept Therapeutics Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 12.32 Bn | 227.36 | 14.83 | 12.02 Bn |
| 69 | MOG-A | Moog Inc. | secondary | I-02 | Aerospace and Defense | IG-01 | 11.67 Bn | 30.96 | 2.70 | 11.61 Bn |
| 70 | KYMR | Kymera Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 11.46 Bn | -38.25 | 109.14 | 10.77 Bn |
| 71 | AXSM | Axsome Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.87 Bn | -70.72 | 14.00 | 10.55 Bn |
| 72 | GKOS | GLAUKOS Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.72 Bn | -68.08 | 17.50 | 10.61 Bn |
| 73 | PRAX | Praxis Precision Medicines, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 10.26 Bn | -26.91 | — | 9.50 Bn |
| 74 | GMED | Globus Medical Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.10 Bn | 18.86 | 3.21 | 9.50 Bn |
| 75 | NUVL | Nuvalent, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.75 Bn | -27.07 | — | 9.75 Bn |
| 76 | CYTK | Cytokinetics Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.74 Bn | -13.28 | 143.99 | 8.58 Bn |
| 77 | PODD | Insulet Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 9.69 Bn | 25.80 | 3.17 | 9.15 Bn |
| 78 | GPCR | Structure Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.52 Bn | -50.59 | — | 9.52 Bn |
| 79 | IONS | Ionis Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 9.29 Bn | -43.79 | 10.63 | 7.24 Bn |
| 80 | CRNX | Crinetics Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 8.99 Bn | -17.90 | 213.22 | 8.99 Bn |
| 81 | ATR | Aptargroup, Inc. | secondary | I-04 | Machinery | IG-02 | 7.76 Bn | 21.38 | 1.97 | 7.56 Bn |
| 82 | ALKS | Alkermes plc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 7.59 Bn | 114.79 | 4.55 | 6.93 Bn |
| 83 | GIFLF | Grifols SA | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 7.54 Bn | 29.70 | 0.46 | 9.09 Bn |
| 84 | HNGE | Hinge Health, Inc. | secondary | H-16 | Healthcare Providers | HG-04 | 7.30 Bn | 67.98 | 10.14 | 6.91 Bn |
| 85 | LNTH | Lantheus Holdings, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 6.57 Bn | 23.87 | 4.22 | 5.98 Bn |
| 86 | BLCO | Bausch & Lomb Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.41 Bn | -39.35 | 1.20 | 6.04 Bn |
| 87 | MMED | MiniMed Group, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.38 Bn | -20.45 | 2.00 | 6.17 Bn |
| 88 | HIMS | Hims & Hers Health, Inc. | secondary | H-16 | Healthcare Providers | HG-04 | 6.37 Bn | -44.84 | 2.47 | 5.53 Bn |
| 89 | BLRX | BioLineRx Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.30 Bn | -703.30 | 4,524.98 | 6.30 Bn |
| 90 | BLTE | Belite Bio, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.20 Bn | 0.08 | — | 6.20 Bn |
| 91 | TVTX | Travere Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.19 Bn | -142.43 | 10.47 | 6.07 Bn |
| 92 | LQDA | Liquidia Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.09 Bn | 43.92 | 13.50 | 5.80 Bn |
| 93 | NOVT | Novanta Inc | secondary | I-04 | Machinery | IG-02 | 6.02 Bn | 113.76 | 5.85 | 5.30 Bn |
| 94 | TFX | Teleflex Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 5.96 Bn | -5.29 | 2.64 | 5.66 Bn |
| 95 | AMRN | Amarin Corp Plc\Uk | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 5.95 Bn | -219.19 | 31.92 | 5.63 Bn |
| 96 | DBVT | DBV Technologies S.A. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.83 Bn | -33.14 | 1,162.23 | 5.66 Bn |
| 97 | LGND | Ligand Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.74 Bn | 29.09 | 19.75 | 4.38 Bn |
| 98 | STVN | Stevanato Group S.p.A. | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 5.58 Bn | 35.53 | 3.90 | 5.47 Bn |
| 99 | MMSI | Merit Medical Systems Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 5.20 Bn | 35.73 | 3.29 | 4.75 Bn |
| 100 | ERAS | Erasca, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.02 Bn | -17.50 | — | 5.02 Bn |
| 101 | FMCQF | Fresenius Medical Care AG | secondary | H-14 | Healthcare Providers | HG-04 | 4.79 Bn | 4.57 | 0.17 | 4.09 Bn |
| 102 | ACAD | Acadia Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.78 Bn | 12.56 | 4.20 | 3.82 Bn |
| 103 | EWTX | Edgewise Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.65 Bn | -23.57 | — | 4.65 Bn |
| 104 | HAE | Haemonetics Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.64 Bn | 48.20 | 3.43 | 4.42 Bn |
| 105 | LIVN | LivaNova PLC | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.35 Bn | 22.94 | 2.95 | 3.83 Bn |
| 106 | ITGR | Integer Holdings Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.30 Bn | 33.48 | 2.33 | 4.28 Bn |
| 107 | DFTX | Definium Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.20 Bn | -11.87 | — | 4.20 Bn |
| 108 | ICUI | Icu Medical Inc/De | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.06 Bn | 121.75 | 1.88 | 3.76 Bn |
| 109 | INDV | Indivior Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.06 Bn | 11.42 | 3.04 | 3.83 Bn |
| 110 | DNLI | Denali Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.01 Bn | -7.84 | 1,112.24 | 4.01 Bn |
| 111 | IRTC | iRhythm Holdings, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 4.00 Bn | -286.66 | 4.84 | 3.41 Bn |
| 112 | MANE | Veradermics, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.96 Bn | -46.00 | — | 3.96 Bn |
| 113 | CPRX | CATALYST PHARMACEUTICALS, INC. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.85 Bn | 17.94 | 6.45 | 3.09 Bn |
| 114 | ELVN | Enliven Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.84 Bn | -45.61 | — | 3.84 Bn |
| 115 | TLPPF | Telix Pharmaceuticals Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.72 Bn | -521.64 | 4.64 | 3.43 Bn |
| 116 | TARS | Tarsus Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.67 Bn | -78.22 | 6.05 | 3.22 Bn |
| 117 | PLSE | Pulse Biosciences, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 3.62 Bn | -44.91 | 4,618.48 | 3.62 Bn |
| 118 | OGN | Organon & Co. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.61 Bn | 17.25 | 0.59 | 2.47 Bn |
| 119 | RCUS | Arcus Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.57 Bn | -7.77 | 30.54 | 2.87 Bn |
| 120 | RSMDF | Resmed Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 3.54 Bn | 2.34 | 0.63 | 2.07 Bn |
| 121 | IPGP | Ipg Photonics Corp | secondary | I-04 | Machinery | IG-02 | 3.34 Bn | 121.26 | 3.13 | 2.47 Bn |
| 122 | IMNM | Immunome Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.97 Bn | -10.97 | 593.06 | 2.45 Bn |
| 123 | TMDX | TransMedics Group, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.96 Bn | 17.27 | 4.42 | 2.48 Bn |
| 124 | NRIX | Nurix Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.92 Bn | -8.57 | 79.55 | 2.48 Bn |
| 125 | NAMS | NewAmsterdam Pharma Co N.V. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.92 Bn | -11.26 | 410.25 | 2.92 Bn |
| 126 | ZLAB | Zai Lab Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.83 Bn | -15.06 | 6.30 | 2.13 Bn |
| 127 | CURLF | Curaleaf Holdings, Inc. | secondary | S-09 | Tobacco and Cannabis | SG-04 | 2.72 Bn | -22.98 | 2.08 | 2.63 Bn |
| 128 | CHRN | ChronoScale Holdings Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.65 Bn | -55.84 | 41.09 | 2.64 Bn |
| 129 | SLS | SELLAS Life Sciences Group, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.63 Bn | -81.13 | — | 2.63 Bn |
| 130 | MLYS | Mineralys Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.63 Bn | -7.53 | — | 2.63 Bn |
| 131 | TAK | Takeda Pharmaceutical Co Ltd | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.62 Bn | 4.56 | 0.06 | -3.18 Bn |
| 132 | TRVI | Trevi Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.62 Bn | -62.02 | — | 2.62 Bn |
| 133 | ATRC | AtriCure, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.59 Bn | 245.89 | 4.56 | 2.43 Bn |
| 134 | AXGN | Axogen, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.55 Bn | -172.32 | 10.15 | 2.44 Bn |
| 135 | BEIGF | BeOne Medicines Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.48 Bn | 3.74 | 0.40 | -2.62 Bn |
| 136 | HRMY | Harmony Biosciences Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.44 Bn | 13.66 | 2.54 | 1.63 Bn |
| 137 | SUPN | Supernus Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.43 Bn | -28.60 | 3.09 | 2.06 Bn |
| 138 | BCRX | Biocryst Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.30 Bn | -5.97 | 4.30 | 1.95 Bn |
| 139 | NUVB | Nuvation Bio Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.29 Bn | -21.16 | 13.47 | 2.29 Bn |
| 140 | ESTA | Establishment Labs Holdings Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.23 Bn | -57.44 | 9.09 | 2.16 Bn |
| 141 | BHVN | Biohaven Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.23 Bn | -3.80 | — | 1.96 Bn |
| 142 | PVLA | Palvella Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.20 Bn | -41.56 | — | 1.89 Bn |
| 143 | UFPT | Ufp Technologies Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.18 Bn | 30.19 | 3.46 | 2.17 Bn |
| 144 | ADMA | Adma Biologics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.16 Bn | 12.96 | 4.21 | 2.02 Bn |
| 145 | AUPH | Aurinia Pharmaceuticals Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.10 Bn | 6.68 | 6.73 | 1.65 Bn |
| 146 | ZBIO | Zenas BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.04 Bn | -4.91 | 2,043.58 | 2.04 Bn |
| 147 | VCEL | Vericel Corp | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.99 Bn | 79.19 | 6.49 | 1.82 Bn |
| 148 | INSP | Inspire Medical Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.92 Bn | 14.21 | 2.14 | 1.60 Bn |
| 149 | NVCR | NovoCure Ltd | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.91 Bn | -12.88 | 2.74 | 1.47 Bn |
| 150 | LMAT | Lemaitre Vascular Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.82 Bn | 27.65 | 6.92 | 1.44 Bn |
| 151 | BLFS | Biolife Solutions Inc | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 1.73 Bn | 29.78 | 16.78 | 1.64 Bn |
| 152 | AAPG | Ascentage Pharma Group International | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.66 Bn | -9.11 | 20.12 | 1.38 Bn |
| 153 | ETON | Eton Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.65 Bn | 172.38 | 16.42 | 1.62 Bn |
| 154 | NVAX | Novavax Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.61 Bn | -6.49 | 3.89 | 0.89 Bn |
| 155 | SCNI | Scinai Immunotherapeutics Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.59 Bn | -189.55 | 922.01 | 1.58 Bn |
| 156 | INVA | Innoviva, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.56 Bn | 7.92 | 3.02 | 0.98 Bn |
| 157 | OMCL | Omnicell, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.52 Bn | 38.92 | 1.22 | 1.23 Bn |
| 158 | RARE | Ultragenyx Pharmaceutical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.50 Bn | -3.25 | 2.09 | 1.21 Bn |
| 159 | XERS | Xeris Biopharma Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.46 Bn | -85.23 | 4.36 | 1.34 Bn |
| 160 | ATEC | Alphatec Holdings, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.46 Bn | -13.27 | 1.79 | 1.34 Bn |
| 161 | LBRX | Lb Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.46 Bn | -24.05 | — | 1.46 Bn |
| 162 | AVBP | ArriVent BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.43 Bn | -8.71 | — | 1.43 Bn |
| 163 | HROW | Harrow, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.42 Bn | -42.38 | 5.14 | 1.33 Bn |
| 164 | CNMD | CONMED Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.41 Bn | 24.99 | 1.03 | 1.37 Bn |
| 165 | OMER | Omeros Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.38 Bn | 80.59 | 35.80 | 1.38 Bn |
| 166 | KMTS | Kestra Medical Technologies, Ltd. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.36 Bn | -10.35 | 14.33 | 1.00 Bn |
| 167 | TNDM | Tandem Diabetes Care Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.34 Bn | -21.17 | 1.29 | 0.88 Bn |
| 168 | IART | Integra Lifesciences Holdings Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.25 Bn | -172.56 | 0.76 | 0.98 Bn |
| 169 | AORT | Artivion, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.24 Bn | -391.09 | 2.63 | 1.16 Bn |
| 170 | MNKD | Mannkind Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.23 Bn | -28.28 | 3.13 | 1.12 Bn |
| 171 | MGTX | MeiraGTx Holdings plc | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.23 Bn | 7.47 | 3.08 | 1.09 Bn |
| 172 | CRVS | Corvus Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.23 Bn | -25.72 | — | 1.01 Bn |
| 173 | PRCT | PROCEPT BioRobotics Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.19 Bn | -10.41 | 3.54 | 0.92 Bn |
| 174 | STAA | Staar Surgical Co | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.19 Bn | 61.43 | 3.49 | 1.00 Bn |
| 175 | OPK | Opko Health, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.18 Bn | -31.20 | 2.01 | 0.88 Bn |
| 176 | THRM | Gentherm Inc | secondary | I-04 | Machinery | IG-02 | 1.17 Bn | 10.85 | 0.74 | 0.96 Bn |
| 177 | DRTS | Alpha Tau Medical Ltd. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.17 Bn | 12.71 | — | 1.07 Bn |
| 178 | AVNS | Avanos Medical, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.17 Bn | -15.62 | 1.63 | 1.10 Bn |
| 179 | OLMA | Olema Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.11 Bn | -5.43 | — | 1.11 Bn |
| 180 | KURA | Kura Oncology, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.08 Bn | -4.56 | 14.04 | 1.08 Bn |
| 181 | IRMD | Iradimed Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.07 Bn | 46.59 | 12.40 | 1.01 Bn |
| 182 | MRVI | Maravai Lifesciences Holdings, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 1.04 Bn | -7.63 | 4.97 | 0.97 Bn |
| 183 | PCRX | Pacira BioSciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.01 Bn | 68.91 | 1.35 | 0.76 Bn |
| 184 | MNPR | Monopar Therapeutics | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.98 Bn | -70.49 | — | 0.92 Bn |
| 185 | INMD | InMode Ltd. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.96 Bn | 11.20 | 2.57 | 0.48 Bn |
| 186 | LXRX | Lexicon Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.96 Bn | -15.21 | 23.06 | 0.77 Bn |
| 187 | DSGN | Design Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.95 Bn | -11.75 | — | 0.74 Bn |
| 188 | SGP | SpyGlass Pharma, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.94 Bn | -48.72 | — | 0.94 Bn |
| 189 | BVS | Bioventus Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.94 Bn | 15.21 | 1.61 | 0.91 Bn |
| 190 | QDEL | QuidelOrtho Corp | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.88 Bn | — | — | 0.76 Bn |
| 191 | BBNX | Beta Bionics, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.85 Bn | -11.65 | 7.15 | 0.67 Bn |
| 192 | AVR | Anteris Technologies Global Corp. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.84 Bn | -10.08 | 373.60 | 0.84 Bn |
| 193 | SIBN | SI-BONE, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.84 Bn | -57.25 | 3.91 | 0.69 Bn |
| 194 | ACRS | Aclaris Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.83 Bn | -10.47 | 101.33 | 0.83 Bn |
| 195 | VSTM | Verastem, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.81 Bn | -7.05 | 9.28 | 0.68 Bn |
| 196 | COLL | Collegium Pharmaceutical, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.77 Bn | 16.04 | 0.95 | 0.62 Bn |
| 197 | PHAT | Phathom Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.74 Bn | -7.58 | 3.11 | 0.56 Bn |
| 198 | ZVRA | Zevra Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.73 Bn | 12.53 | 5.36 | 0.51 Bn |
| 199 | GYRE | Gyre Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.71 Bn | -38.37 | 5.93 | 0.65 Bn |
| 200 | IVEVF | Inventiva S.A. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.69 Bn | 7.19 | 132.94 | 0.69 Bn |
| 201 | SSII | SS Innovations International, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.67 Bn | -43.53 | 12.74 | 0.65 Bn |
| 202 | EVO | Evotec SE | secondary | H-11 | Pharma Services | HG-03 | 0.64 Bn | — | — | 0.22 Bn |
| 203 | AQST | Aquestive Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | -8.24 | 11.91 | 0.55 Bn |
| 204 | CRMD | CorMedix Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | 5.09 | 1.71 | 0.38 Bn |
| 205 | ANGO | Angiodynamics Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.63 Bn | -17.13 | 1.97 | 0.58 Bn |
| 206 | MPLT | MapLight Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.62 Bn | -3.07 | — | 0.62 Bn |
| 207 | OCS | Oculis Holding AG | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.61 Bn | -347,652.42 | — | 0.61 Bn |
| 208 | BRSYF | Brainsway Ltd. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.59 Bn | 60.53 | 9.76 | 0.53 Bn |
| 209 | DCTH | Delcath Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.58 Bn | 1,176.30 | 6.09 | 0.49 Bn |
| 210 | EOLS | Evolus, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.57 Bn | -16.74 | 1.82 | 0.53 Bn |
| 211 | IRD | Opus Genetics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.55 Bn | -5.67 | 55.90 | 0.46 Bn |
| 212 | NVCT | Nuvectis Pharma, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.55 Bn | -18.18 | — | 0.55 Bn |
| 213 | OVID | Ovid Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.54 Bn | -15.57 | 339.28 | 0.42 Bn |
| 214 | KIDS | Orthopediatrics Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.53 Bn | -13.35 | 2.10 | 0.48 Bn |
| 215 | SPRY | ARS Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.53 Bn | -2.39 | 4.52 | 0.38 Bn |
| 216 | SENS | Senseonics Holdings, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.53 Bn | -4.83 | 10.88 | 0.29 Bn |
| 217 | PRLD | Prelude Therapeutics Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.51 Bn | -7.63 | 22.95 | 0.23 Bn |
| 218 | CERS | Cerus Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.50 Bn | -27.93 | 2.02 | 0.45 Bn |
| 219 | NPCE | NeuroPace Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.50 Bn | -26.27 | 5.05 | 0.45 Bn |
| 220 | TCMD | Tactile Systems Technology Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.49 Bn | 19.85 | 1.40 | 0.41 Bn |
| 221 | DDD | 3D Systems Corp | secondary | I-12 | Machinery | IG-02 | 0.49 Bn | -9.71 | 1.26 | 0.36 Bn |
| 222 | ANL | Adlai Nortye Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.49 Bn | -10.27 | 78.36 | 0.26 Bn |
| 223 | RGNX | REGENXBIO Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.46 Bn | -2.58 | 2.42 | 0.35 Bn |
| 224 | XFOR | X4 Pharmaceuticals, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.45 Bn | -4.96 | 28.22 | 0.25 Bn |
| 225 | MTLS | Materialise Nv | secondary | T-20 | Business Applications | TG-03 | 0.45 Bn | 28.98 | 1.40 | 0.45 Bn |
| 226 | PALI | Palisade Bio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.44 Bn | -12.52 | 883.58 | 0.32 Bn |
| 227 | SGHT | Sight Sciences, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.44 Bn | -20.21 | 5.26 | 0.36 Bn |
| 228 | IKT | Inhibikase Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.42 Bn | -6.46 | — | 0.26 Bn |
| 229 | CLPT | ClearPoint Neuro, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.42 Bn | -14.45 | 9.96 | 0.39 Bn |
| 230 | CARL | Carlsmed, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.42 Bn | -11.53 | 6.62 | 0.31 Bn |
| 231 | TTRX | Turn Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.42 Bn | -54.08 | — | 0.42 Bn |
| 232 | VTVT | vTv Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.41 Bn | -86.82 | 11.21 | 0.41 Bn |
| 233 | SI | Shoulder Innovations, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.41 Bn | -11.78 | 6.87 | 0.31 Bn |
| 234 | EVMN | Evommune, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.40 Bn | -4.18 | 39.60 | 0.20 Bn |
| 235 | EYPT | EyePoint, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.39 Bn | -1.25 | 138.08 | 0.20 Bn |
| 236 | OFIX | Orthofix Medical Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.37 Bn | -8.38 | 0.44 | 0.26 Bn |
| 237 | OBIO | Orchestra BioMed Holdings, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.34 Bn | -5.75 | 10.72 | 0.15 Bn |
| 238 | ACHV | Achieve Life Sciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.33 Bn | — | — | 0.33 Bn |
| 239 | SION | Sionna Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.33 Bn | -3.41 | — | 0.33 Bn |
| 240 | CV | CapsoVision, Inc | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.33 Bn | -12.09 | 23.00 | 0.32 Bn |
| 241 | VNDA | Vanda Pharmaceuticals Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -1.15 | 1.46 | 0.15 Bn |
| 242 | EMBC | Embecta Corp. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.31 Bn | 3.56 | 0.31 | 0.09 Bn |
| 243 | STRO | Sutro Biopharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.31 Bn | -2.71 | 3.43 | 0.14 Bn |
| 244 | SWKHL | SWK Holdings Corp | secondary | F-06 | Lending and Credit | FG-02 | 0.31 Bn | -332.24 | 7.43 | 0.27 Bn |
| 245 | TMCI | Treace Medical Concepts, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.30 Bn | -5.29 | 1.48 | 0.26 Bn |
| 246 | SMTI | Sanara MedTech Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.30 Bn | -9.83 | 2.10 | 0.30 Bn |
| 247 | IMRX | Immuneering Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | -5.13 | — | 0.30 Bn |
| 248 | EBS | Emergent BioSolutions Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | -1.68 | 0.38 | 0.16 Bn |
| 249 | FULC | Fulcrum Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -3.25 | — | 0.29 Bn |
| 250 | TLSI | TriSalus Life Sciences, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.28 Bn | -4.78 | 6.22 | 0.23 Bn |
| 251 | ANIK | Anika Therapeutics, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.28 Bn | -131.04 | 2.31 | 0.24 Bn |
| 252 | ZNTL | Zentalis Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.28 Bn | -1.98 | — | 0.28 Bn |
| 253 | RXST | RxSight, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.27 Bn | -6.99 | 2.12 | -0.13 Bn |
| 254 | AKBA | Akebia Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.27 Bn | -8.95 | 1.21 | 0.11 Bn |
| 255 | AHG | Akso Health Group | secondary | H-16 | Healthcare Providers | HG-04 | 0.26 Bn | — | 18.75 | 0.26 Bn |
| 256 | MGNX | Macrogenics Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.26 Bn | -16.04 | 1.54 | 0.14 Bn |
| 257 | PROF | Profound Medical Corp. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.25 Bn | 3.73 | 13.01 | 0.21 Bn |
| 258 | OSUR | Orasure Technologies Inc | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.24 Bn | — | 2,434.68 | 0.04 Bn |
| 259 | CELG-RI | Bristol Myers Squibb Co | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.23 Bn | 0.03 | 0.00 | -10.83 Bn |
| 260 | ELMD | Electromed, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.23 Bn | 20.13 | 3.08 | 0.21 Bn |
| 261 | SIGA | Siga Technologies Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.23 Bn | — | — | 0.07 Bn |
| 262 | UTMD | Utah Medical Products Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.22 Bn | 22.54 | 6.16 | 0.14 Bn |
| 263 | TNXP | Tonix Pharmaceuticals Holding Corp. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | -1.34 | 7.37 | 0.21 Bn |
| 264 | STIM | Neuronetics, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.21 Bn | -6.65 | 1.36 | 0.19 Bn |
| 265 | FTH | Faeth Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | -1.08 | — | 0.21 Bn |
| 266 | DERM | Journey Medical Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | -56.78 | 3.04 | 0.18 Bn |
| 267 | PDEX | Pro Dex Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.21 Bn | 15.04 | 2.65 | 0.20 Bn |
| 268 | ORGO | Organogenesis Holdings Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.20 Bn | -2.04 | 0.45 | 0.16 Bn |
| 269 | ACOG | Alpha Cognition Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -7.42 | 15.21 | 0.16 Bn |
| 270 | CRDL | Cardiol Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -7.68 | — | 0.20 Bn |
| 271 | NERV | Minerva Neurosciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -30.30 | — | 0.20 Bn |
| 272 | SLGL | Sol-Gel Technologies Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -18.55 | 108.38 | 0.15 Bn |
| 273 | MCUJF | Medicure Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -37.45 | 8.18 | 0.19 Bn |
| 274 | NNBR | Nn Inc | secondary | I-09 | Machinery | IG-02 | 0.19 Bn | -4.99 | 0.41 | 0.17 Bn |
| 275 | LONA | LeonaBio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.18 Bn | -1.51 | — | 0.13 Bn |
| 276 | HSDT | Solana Co | secondary | F-22 | Capital Markets | FG-05 | 0.18 Bn | -1.15 | 14.93 | 0.18 Bn |
| 277 | LENZ | LENZ Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.16 Bn | -1.25 | 7.50 | 0.16 Bn |
| 278 | RANI | Rani Therapeutics Holdings, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.16 Bn | -4.88 | 32.90 | 0.16 Bn |
| 279 | MENS | Jyong Biotech Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.16 Bn | -46.69 | — | 0.16 Bn |
| 280 | FOCL | Edap Tms Sa | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.16 Bn | -5.01 | 2.31 | 0.14 Bn |
| 281 | WALD | Waldencast plc | secondary | S-12 | Household and Personal Products | SG-05 | 0.15 Bn | -1.83 | 0.67 | 0.12 Bn |
| 282 | TNYA | Tenaya Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -1.42 | 109.57 | 0.15 Bn |
| 283 | KRMD | KORU Medical Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.15 Bn | -62.25 | 3.24 | 0.14 Bn |
| 284 | IFRX | InflaRx N.V. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | 0.00 | 1,805.31 | -0.04 Bn |
| 285 | INGN | Inogen Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.14 Bn | -6.65 | 0.40 | 0.04 Bn |
| 286 | SPRB | Spruce Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | -2.87 | — | 0.14 Bn |
| 287 | HUMA | Humacyte, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | -1.15 | 65.00 | 0.14 Bn |
| 288 | BMEA | Biomea Fusion, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -2.35 | — | 0.13 Bn |
| 289 | APYX | Apyx Medical Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.13 Bn | -15.29 | 2.26 | 0.10 Bn |
| 290 | CDXS | Codexis, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.13 Bn | -4.27 | 1.69 | 0.08 Bn |
| 291 | STXS | Stereotaxis, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.13 Bn | -5.62 | 4.14 | 0.11 Bn |
| 292 | NRXP | NRX Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -6.12 | 37.53 | 0.10 Bn |
| 293 | RFL | Rafael Holdings, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.12 Bn | -4.47 | 121.80 | 0.12 Bn |
| 294 | VANI | Vivani Medical, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.12 Bn | -4.32 | — | 0.10 Bn |
| 295 | INO | Inovio Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.11 Bn | -1.45 | — | 0.11 Bn |
| 296 | VRCA | Verrica Pharmaceuticals Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.11 Bn | -3.55 | 3.68 | 0.10 Bn |
| 297 | GUTS | Fractyl Health, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.11 Bn | -0.86 | — | 0.11 Bn |
| 298 | AARD | Aardvark Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.11 Bn | -1.56 | — | 0.04 Bn |
| 299 | LNSR | LENSAR, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.10 Bn | 6.52 | 1.72 | 0.09 Bn |
| 300 | MBOT | Microbot Medical Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.10 Bn | -6.92 | 84.41 | 0.10 Bn |